- Home
- CRIS vs MDCX Comparison
CRIS vs MDCX Comparison
Compare CRIS & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$0.76
Company Overview
Basic Information| Metric | CRIS | MDCX |
|---|---|---|
| Founded | 2000 | 2008 |
| Country | United States | United States |
| Employees | N/A | 12 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.0M | 26.2M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | CRIS | MDCX |
|---|---|---|
| Price | $0.76 | $0.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $16.50 | ★ $23.50 |
| AVG Volume (30 Days) | 109.1K | ★ 8.2M |
| Earning Date | 03-19-2026 | 03-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 23.21 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,898,000.00 | N/A |
| Revenue This Year | $6.13 | N/A |
| Revenue Next Year | $7.86 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 31.50 | N/A |
| 52 Week Low | $0.77 | $0.37 |
| 52 Week High | $3.13 | $8.90 |
Technical Indicators
Market Signals| Indicator | CRIS | MDCX |
|---|---|---|
| Relative Strength Index (RSI) | 29.02 | 31.88 |
| Support Level | N/A | $0.37 |
| Resistance Level | $1.04 | $1.43 |
| Average True Range (ATR) | 0.08 | 0.15 |
| MACD | -0.03 | -0.03 |
| Stochastic Oscillator | 4.08 | 9.52 |
Price Performance
Historical Comparison CRIS
MDCX
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About MDCX Medicus Pharma Ltd.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.